Sinovac expects to be able to manufacture 300 million doses annually and aims to complete the construction of a second production facility by the end ... Dec 07
The Lancet Infectious Diseases: Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers, preliminary ... Nov 18
-Advertisements-